AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Pulse oximeter

New rule could keep us from finding the next pulse oximeter failure

| 6 Min Read
Figure holds a sign with the word stop toward another individual

6 mistakes to avoid when starting your private practice

| 7 Min Read
Team of doctors hold giant magnifying glass over human digestive system

How AI clears the way for colonoscopy screening

| 8 Min Read
Doctor giving patient a joint exam in doctor's office

What doctors want patients to know about osteoarthritis

| 8 Min Read